Clinical Oncology Next Generation Sequencing Market Growing to Unveil a Remarkable CAGR of 15.1%, Trends Industry Analysis, Top Manufacturers, Growth, Opportunities & Forecast 2029

Clinical Oncology Next Generation Sequencing Market research report explores the major parameters for Healthcare industry namely market analysis, market definition, market segmentation, key developments in the market, competitive analysis, and research methodology. With the market statistics included in this market document, getting a global perspective for the international business has become quite easy. The report normally includes major manufacturers, suppliers, distributors, traders, customers, investors, major types, and major applications. The universal Clinical Oncology Next Generation Sequencing Market report also presents the company profile, product specifications, capacity, production value, and 2022-2029 market shares for each company under Healthcare industry.

Clinical Oncology Next Generation Sequencing Market survey report includes the most important market insights that progress the business to the next level of growth and success. The market factors can be listed as; emerging trends, product usage, motivating factors for customers and competitors, market restraints, brand positioning, and customer behaviour. In market document, industry trends are put together on macro level which helps businesses understand market landscape and possible future issues. Market parameters covered in the best Clinical Oncology Next Generation Sequencing Market report mainly range from market definition, currency and pricing, market segmentation, market overview, premium insights, key insights to company profile of the key market players.

Visit full Study Report @ https://www.databridgemarketresearch.com/reports/global-clinical-oncology-next-generation-sequencing-market

According to the American Cancer Society, 1.7 million additional cancer cases and 0.6 million cancer deaths occurred in the United States in 2019. Lung, prostate, bladder, and female breast cancer are the four most common cancers worldwide, accounting for 43% of all new cancer cases. As a result, demand for clinical oncology next-generation sequencing is predicted to rise as cancer incidence rates rise globally. Clinical oncology next-generation sequencing companies are increasingly investing in workflow automation to improve accuracy and lower sample-to-sample variability.

Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Some of the major players operating in the clinical oncology next generation sequencing market are:

Illumina, Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Agilent Technologies Inc. (U.S.)
Myriad Genetics Inc. (U.S.)
BGI (China)
Perkin Elmer Inc. (U.S.)
Foundation Medicine Inc. (U.S.)
PacBio (U.S.)
Oxford Nanopore Technologies plc. (U.K.)
Paradigm Diagnostics Inc. (U.S.)
Caris Life Sciences (Japan)
Partek, Incorporated (U.S.)
Eurofins Scientific (Luxembourg)
Qiagen (Germany)

Recent Development

In January 2022, Agendia, Inc., a global pioneer in breast cancer precision medicine, announced a multi-year collaboration with Illumina to co-develop in vitro diagnostic (IVD) assays for oncology testing.
In October 2021, Roche introduced the AVENIO tumour tissue CGP kit to make tailored cancer research more accessible.

 Browse More Reports

https://dbmrmarkett.blogspot.com/2023/07/india-healthcare-it-market-trends.html

https://dbmrmarkett.blogspot.com/2023/07/ambulatory-x-ray-devices-market-trends.html

https://dbmrmarkett.blogspot.com/2023/07/lung-cancer-diagnostics-market-trends.html

https://dbmrmarkett.blogspot.com/2023/07/cervical-cancer-diagnostic-market.html

About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. "Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - corporatesales@databridgemarketresearch.com

This release was published on openPR.